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Abstract Primary thunderclap headache (TCH) is a rare
condition, of which the onset can be triggered by coughing,
exercise, and sexual activity. Micturition is a recognized
trigger of secondary TCH with pheochromocytoma in
bladder, but not of primary TCH. We describe a patient
with an apparent primary TCH, which repeatedly occurred
immediately after micturition until she achieved a thera-
peutic dosage of nimodipine.
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Introduction
Thunderclap headache (TCH) is a hyper-acute, severe
headache that reaches maximum intensity at onset. This
type of headache is frequently described by patient as
being ‘the worst headache of his or her life’. The term
TCH was ﬁrst used in the description of the headache
caused by unruptured intracerebral aneurysms [1].
Because of its hyper-acute and severe characteristics, it is
described as thunderclap [2]. TCH could be the conditions
secondary to subarachnoid hemorrhage, unruptured
intracranial aneurysm, cerebral venous sinus thrombosis,
cervical artery dissection, spontaneous intracranial hypo-
tension, acute hypertensive crisis, or a third ventricle
colloid cyst [3]. But primary TCH has been described as a
distinct entity when the known causes have been exclu-
ded. A primary TCH may be triggered by coughing,
exercise and sexual activity and thus be classiﬁed as
primary cough headache, primary exertional headache and
primary headache associated with sexual activity [4].
There are also micturition-triggered TCHs though these
conditions are very rare, but all the reported cases were
found attributed to bladder pheochromocytoma and the
headache symptom was associated with elevation of blood
pressure following micturition [5, 6]. Here, we report, for
the ﬁrst time, a case of recurrent TCH triggered exclu-
sively by micturition with neither pheochromocytoma in
bladder nor elevation of blood pressure following
micturition.
Case report
A 52 year-old woman presented with episodes of sudden-
bursting headache immediately after micturition for the last
4 days before admission to our department. She described
the onset of headache as sudden, severe, and as if she had
been ‘hit in the head by a car’. She characterized it as a
distending headache which ﬁrst occurred on the bilateral
temporal region and progressively spread to all the head
within 30 s. The headache reached its peak almost at onset
and was rated by her as 9/10 in severity. The headache was
accompanied by nausea and vomiting, but not by sense of
vertigo or limb incoordination. It lasted for 1–2 h and
disappeared gradually. There was no personal history of
headache or other neurological disorders. She had been
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relievers failed to ease the pain.
On examination, she was alert, oriented and anxious,
with a blood pressure (BP) of 108/64 mmHg, a regular
heartbeat of 68 beats/minute, and a temperature of 36.8C.
Her neurological and general examination did not reveal
any pathologic ﬁndings. For several times during headache
attacks immediately after micturition, her BP was moni-
tored to be in normal range.
Findings from laboratory surveys, including antinuclear
antibody, C-reactive protein level, erythrocyte sedimenta-
tion rate, anticardiolipin antibody, anti-neutrophil cyto-
plasmic antibodies, urine tests, thyroid functions, lupus
anticoagulant, serum catecholamine, were either negative
or within normal limits.
Cerebrospinal ﬂuid (CSF) examination, performed 2 h
after one headache attack, had a normal opening pressure,
revealed clear ﬂuid with a leukocyte count of 3/mm
3,a
protein level of 0.39 g/l (normal range, 0.15–0.45 g/L), and
a glucose level of 3.2 mmol/L (normal range,
2.5–4.4 mmol/L). CSF viral antibody test revealed nega-
tive for all the familiar virus including hepatitis B and C,
cytomegalovirus, herpes simplex virus, Epstein-Barr virus.
Brain computerized tomography (CT) scan, magnetic
resonance imaging (MRI), and magnetic resonance angiog-
raphy (MRA) showed no signs of intracerebral hemorrhage,
subarachnoidhemorrhage,infarction,thrombosis,dissection
or aneurysm of the extracranial or intracranial arteries. The
contrast-enhanced CT scan of the abdomen revealed no
abnormalities. Electroencephalogram (EEG) was normal.
Testing for anxiety and depressive disorders was conducted
in the headache-free time among the attacking days,
revealingascoreof16ontheHamiltonanxietyscale(HAM-
A) (mild anxiety C14) and 9 on the Hamilton depression
scale (HAM-D) (mild depression[7) [7, 8].
Antianxiety treatment with ﬂupentixol and melitracen
tablets (one tablet contains 0.5 mg ﬂupentixol and 10 mg
melitracen) at a dosage of one tablet in the morning and
one tablet at noon, together with antalgesic, pregabalin, at a
dosage of 150 mg daily, did not prevent the recurrence of
micturitional headaches. During this time, she would
micturate two to three times a day and each micturition was
followed by a TCH. One week later, antianxietic and ant-
algesic were substituted with oral nimodipine 60 mg every
6 h and the intensity of the micturitional headaches grad-
ually became weaker on the ﬁrst day of nimodipine taking
and no further micturitional headache attacks were noted
on the second day. The patient was then discharged home
in stable condition. Nimodipine treatment was tapered off
gradually in the following 6 weeks, and no headache
recurred. Six-month follow-up revealed that the patient’s
condition was very well except occasional slight headaches
when she met cold-wind.
Discussion
TCH is a severe, hyper-acute headache of the sudden-
bursting type like a ‘clap of thunder’, of which the pain
intensity reaches a peak at onset usually within 60 s. TCH
is considered to have two types: primary TCH and sec-
ondary TCH. Secondary TCH could be attributed to vas-
cular causes including subarachnoid hemorrhage (SAH),
cerebral venous sinus thrombosis (CVST), pituitary apo-
plexy, ischemic stroke, severe hypertension crisis, and
nonvascular causes including spontaneous intracranial
hypotension, third ventricle colloid cyst, intracranial
infections [3]. Our MRI, MRA, and CSF examinations had
excluded these possible underlying causes in this patient. In
very rare situations, micturition can also trigger sudden-
bursting severe headache in patients, but all these reported
cases were accompanied with pheochromocytoma in
bladder [6, 9, 10] and the headaches were usually associ-
ated with elevations of blood pressure following micturi-
tion [5]. The contrast-enhanced abdomen CT scan and the
unelevated blood pressure during headache attack had also
excluded the underlying causes of bladder pheochromo-
cytoma. The headache in our patient seems in consistent
with the presentations of primary TCH. Apart from the
triggering factor micturition, the headache of our patient
met the diagnostic criteria for primary TCH: (i) Severe
head pain, (ii) sudden onset, reaching maximum intensity in
\1 min, lasting from 1 h to 10 days, (iii) Does not recur
regularly over subsequent weeks or months, and (iv) Not
attributed to another disorder. Though evidence that thun-
derclap headache exists as a primary condition is poor,
primary TCH has been described as a distinct entity [4]. A
primary TCH may occur spontaneously while the patient is
at rest or during light activities or may only be triggered by
exertion, sexual activity, coughing and thus be classiﬁed as
primary cough headache, primary exertional headache and
primary headache associated with sexual activity respec-
tively. The TCH in our patient was exclusively triggered by
micturition and there was no serious underlying pathology
identiﬁed to explain this TCH, thus it might be plausible to
consider the micturitional headache as ‘primary’. This
micturitional headache is an unusual headache not deﬁned
by the ICHD-II, therefore the reporting of this case might
be helpful for the more detailed headache classiﬁcation in
the future.
Our patient’s response to nimodipine was dramatic and
impressive during the time when headaches were still
worsening. The close chronological concordance between
headache relief and initiation of oral nimodipine was in
favor of the direct therapeutic effect of nimodipine. Indeed,
nimodipine is currently recommended in aneurysmal sub-
arachnoid hemorrhage in order to prevent vasospasm based
on its role in the relaxation of the smooth muscle of arterial
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TCH in our patient might be associated with cerebral
vasospasm though the vasospasm was not visible by MRA.
Efﬁcacy of nimodipine was reported in primary TCH [12]
as well as in primary bathing TCH [13] with vasospasm
detected or non-detected. It has been suggested that pri-
mary recurrent TCH can be divided in two groups: one
with diffuse vasospasm and the others without any visible
vasospasm by MRA, and primary TCH, to some extent,
share the same spectrum with reversible cerebral vaso-
constriction syndrome (RCVS) based on their similar
clinical features and the same rate of ischemic complica-
tions [14, 15]. The therapeutic efﬁcacy of nimodipine in
vasospasm associated primary TCH and RCVS as well as
in our micturitional headache may suggest a similar path-
ogenic mechanism of vasospasm for both conditions.
Unfortunately, a late control MRA or transcranial Doppler
was not conducted to show any presence of late vasospasm
eventually in this patient. Recently, it has been shown that,
in some patients, the maximal vasospasm detected by
transcranial Doppler or by MRA is respectively at
18–25 days and at 16 ± 10 days after TCH onset [16, 17].
The pathophysiological relationship between micturition
and cerebral vascular change is poorly understood and
speculative. There is anecdotal evidence suggesting that
abdominal support, voluntary diaphragm and abdominal
muscle co-activation, is necessary for effective voiding,
this results in an alteration of intra-abdominal pressure.
This was suggested to have causative relationship to TCH
triggered by singing [18]. This intra-abdominal pressure
alteration may trigger an unclear neural reﬂex resulting in a
cerebral vascular change.
Involvement of non-organic, psychiatric factors should
also be considered to contribute to the recurrent headaches,
as a mild depressive (HAM-D = 16) and a mild anxiety
disorder (HAM-A = 9) were revealed and a distinct phobia
for micturition also found in our patient. Whereas, the
negative result of the antipsychotic treatment seemly
indicated that the psychiatric factors may not play a critical
role in the headache recurrence. Further case reports may
help to elucidate the possible role of psychiatric factors in
the micturitional headache.
In summary, we treated a patient with recurrent TCH
apparently triggered by micturition without any underlying
organic causes, which was responsive to nimodipine dra-
matically. We hypothesize that the pathophysiology of this
primary micturitional headache is associated with cerebral
vasospasm induced by neural reﬂex after the intra-
abdominal pressure is altered.
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